The brief · 26 February 2026

The AI brief, 2026-02-26

An image model at Google, a biotech lab ditching DevOps, and a supercomputer from Lilly hunting for molecules. Three different ways of putting AI to work, today.

1 min read J / K to navigate

Tamarind Bio raises $13.6M to run AlphaFold without the DevOps headache

A biologist who wants to chain AlphaFold, RFdiffusion, and molecular docking usually hits an infrastructure wall before a scientific one. Tamarind Bio sells exactly that missing layer: on-demand access to these models without labs having to stand up their own GPU clusters. Boehringer Ingelheim and Bayer are already customers, which sets this apart from a typical research side-project.

practitioners › $13.6M Series A announced February 26, 2026, bringing total funding to $13.6M; named customers include Boehringer Ingelheim, Bayer, and several academic labs.

Forbes →

Lilly Fires Up a Supercomputer Built for Drug Discovery

Lilly has just switched on LillyPod, a supercomputer powered by more than 1,000 NVIDIA Blackwell Ultra GPUs. The goal: simulate billions of molecular hypotheses in parallel, instead of testing drug candidates one at a time in the lab. If it delivers, it could reshape how fast a drug moves from initial concept to clinical trial.

practitioners › NVIDIA DGX SuperPOD, 1,016 Blackwell Ultra GPUs, 9,000+ petaflops, announced February 26, 2026.

Eli Lilly →